HS Bio’s NeoGenix Laboratoire teams up with UM’s TIDREC

HS Bio director and NeoGenix Lab Group managing director Dr. Kuan Chee Sian

KUALA LUMPUR: Hong Seng Consolidated Bhd’s healthcare arm, HS Bio Sdn Bhd, has entered into a collaborative research and development (R&D) agreement with Universiti Malaysia’s Tropical Infectious Diseases Research and Education Centre (TIDREC).

The R&D agreement was done through HS Bio's wholly-subsidiary, NeoGenix Laboratoire Sdn Bhd.